Vendor Notebook: new tools and acquisitions from OptumRx, ScionHealth, others

Vendor Notebook: new tools and acquisitions from OptumRx, ScionHealth, others

It’s a new year, and healthcare technology vendors are rolling out their latest innovations, market approvals, acquisitions and staffing shake-ups.OptumRx launched Price Edge, a tool that compares pricing for traditional generic drugs to ensure members get the lowest prescription drug prices. A suite of new tools for both patients and providers target aspects of pharmacy logistics that have been known to delay or complicate care, such as getting real-time pharmacy benefits information and obtaining prior authorizations. In October, Optum, UnitedHealth Group’s pharmacy services company, merged with data clearinghouse Change Healthcare. The U.S. Department of Justice tried to block the merger and is appealing the…

Continue Reading
What's ahead for health IT policy and legislation in 2023 

What’s ahead for health IT policy and legislation in 2023 

With Congress providing telehealth waivers as part of its omnibus spending bill at the close of 2022, delaying the “telehealth cliff” for two years, HIMSS says it’s now ready to make the case for permanent reimbursement of virtual care.Also on its policy agenda for the year ahead: advocating for data standardization, offering input for interoperability rulemaking and engaging with agencies and states to increase telehealth access. We spoke with the HIMSS government relations team for their thoughts on those priorities and more in 2023 and beyond.
Making telehealth’s case for cost control
Telehealth has proven to reduce burdens on healthcare providers and improve…

Continue Reading
Needle moving on drug monitoring program efficacy, ONC says

Needle moving on drug monitoring program efficacy, ONC says

A new brief from the Office of the National Coordinator for Health Information Technology data says that one-third of prescribers now access prescription drug-monitoring programs through their electronic health records and 62% reported they used electronic prescribing of controlled substances technologies often – up from 37% in 2019.WHY IT MATTERS
“The use of (PDMPs) and electronic prescribing of controlled substances (EPCS) technology is critical to improving opioid prescribing practices, informing treatment decisions and supporting safe and effective patient care,” wrote Chelsea Richwine and Jordan Everson in a new HealthIT blog post.
They say the new data adds to previous analyses demonstrating the benefits of the systems by…

Continue Reading